Biotech

All Articles

Biogen, UCB report period 3 lupus gain after stopping working earlier trial

.Biogen and also UCB's rely on developing right into phase 3 astride a broken research hopes to have...

Aptadir really hopes brand new RNA inhibitors can turn around tricky cancers cells

.Italian biotech Aptadir Rehabs has launched with the promise that its own pipe of preclinical RNA p...

Wave surfs DMD results to regulators' doors, sending out stock up

.Wave Life Sciences has actually fulfilled its own goal in a Duchenne muscle dystrophy (DMD) study, ...

Sanofi picks brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, occupyin...

Achilles drops tissue treatment program, prepares for discharges after skipping 'office feasibility' objectives

.Achilles Rehabs has actually shreded its approach. The English biotech is actually stopping work on...

Aligos advertises stage 2 MASH win, lowering liver fat as much as 46%

.Aligos Therapeutics is actually trumpeting a midstage gain in metabolic-dysfunction associated stea...

Basilea ratings $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's job establishing brand new antifungals has actually acquired a substantial ...

Capricor sells Europe civil rights to late-stage DMD therapy for $35M

.Possessing already gathered up the U.S. legal rights to Capricor Therapeutics' late-stage Duchenne ...

FDA fragments adcomm for Applied's uncommon ailment medication

.After pushing back the decision date for Applied Rehabs' metabolic condition drug govorestat, the F...

Novo inks $600M NanoVation bargain to analyze hereditary drugs ex-liver

.Novo Nordisk is proceeding its press in to genetic medicines, consenting to compensate NanoVation T...